Tiotropium (Spiriva)
ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.
Tiotropium (Spiriva)
ATI class: Long-acting anticholinergic bronchodilator
Action
- ATI/source-folder candidate for Tiotropium (Spiriva); verify mechanism against the source table before validation.
Therapeutic use
- Review under Lower Respiratory Tract Disorders medication safety.
Nursing assessment
- Assess COPD symptom pattern, breath sounds, inhaler technique, urinary retention risk, glaucoma history, and anticholinergic burden.
- Monitor for dry mouth, urinary retention, blurred vision, and paradoxical bronchospasm.
- Confirm it is not used as a rescue inhaler.
Administration
- Verify route against the order and source table.
Side effects
- Verify common side effects against the source table.
Adverse effects
- Dry mouth
- Urinary retention
- Blurred vision
- Constipation
- Paradoxical bronchospasm
Interactions
- Other anticholinergics increase dry-fast-retain effects.
- Medications with anticholinergic burden increase confusion, constipation, and urinary retention risk.
Contraindications
- See source-specific contraindications and precautions before administration.
Precautions
- Hypersensitivity to tiotropium or related components
- Narrow-angle glaucoma
- Urinary retention or bladder neck obstruction
- Acute bronchospasm
Client teaching
- Use daily as prescribed, not for sudden breathing trouble.
- Avoid getting powder or spray in the eyes.
- Report eye pain, urinary retention, severe constipation, or worsening breathing.
Medication outcomes
- Therapeutic response with no priority adverse effects.
Antidote / rescue
- No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.
NCLEX priority cues
- Rescue inhaler comes before controller inhaler during acute symptoms.
- Other anticholinergics increase retention and confusion risk.
- Worsening dyspnea after inhalation suggests paradoxical bronchospasm.
Medication classes
Source attribution
Related study cards
Shows the medication class, ATI cues, source references, and connected study cards for this drug.
Blocks parasympathetic activity, so secretions dry up, heart rate can rise, and smooth muscle spasms decrease.
Opens narrowed airways by relaxing bronchial smooth muscle or reducing vagal bronchoconstriction.
ATI medication precaution concept.
ATI medication nursing assessment concept.
ATI medication mechanism of action concept.
ATI medication client teaching concept.
ATI medication adverse effect concept.
ATI medication nursing assessment concept.
ATI medication adverse effect concept.
ATI medication adverse effect concept.
ATI medication precaution concept.
ATI medication class concept.